Cancer medications
Treatment plans (regimens)
- 7+3: Cytarabine and daunorubicin, sometimes with midostaurin
- AAVD: Brentuximab vedotin, doxorubicin, vinblastine and dacarbazine
- ABCP: Atezolizumab, bevacizumab, carboplatin and paclitaxel
- ABVD: Doxorubicin, bleomycin, vinblastine and dacarbazine
- AC and dose-dense AC: Doxorubicin and cyclophosphamide
- AIM: Doxorubicin, ifosfamide and mesna
- ATG and cyclosporine: Antithymocyte globulin and cyclosporine, often with eltrombopag
- ATRA and ATO: Tretinoin and arsenic trioxide
- BCP: Bevacizumab, carboplatin and paclitaxel
- BEAM: Carmustine, etoposide, cytarabine and melphalan
- BEP: Bleomycin, etoposide and cisplatin
- BV-CHP: Brentuximab vedotin, cyclophosphamide, doxorubicin and prednisone
- C10403 (CALGB 10403): A pediatric style plan for acute lymphoblastic leukemia that uses many medicines, including vincristine, a steroid (prednisone or dexamethasone), daunorubicin, doxorubicin, pegaspargase, methotrexate, cytarabine, mercaptopurine and cyclophosphamide
- CAPOX: Capecitabine and oxaliplatin
- Carboplatin and etoposide: Carboplatin and etoposide
- Carboplatin and paclitaxel: Carboplatin and paclitaxel
- Carboplatin, pemetrexed and pembrolizumab: Carboplatin, pemetrexed and pembrolizumab
- Cisplatin with radiation: Cisplatin given during a course of radiation therapy
- CLAG-M: Cladribine, cytarabine, filgrastim and mitoxantrone
- CyBorD: Cyclophosphamide, bortezomib and dexamethasone
- DA-EPOCH-R: Dose adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab
- Dose-dense MVAC: Methotrexate, vinblastine, doxorubicin and cisplatin, given every 2 weeks
- DPd: Daratumumab, pomalidomide and dexamethasone
- DRd: Daratumumab, lenalidomide and dexamethasone
- DVd: Daratumumab, bortezomib and dexamethasone
- ERd: Elotuzumab, lenalidomide and dexamethasone
- FCR: Fludarabine, cyclophosphamide and rituximab
- FLAG-IDA: Fludarabine, cytarabine, filgrastim and idarubicin
- FLOT: Fluorouracil, leucovorin, oxaliplatin and docetaxel
- FOLFIRI: Leucovorin, fluorouracil and irinotecan
- FOLFIRINOX: Leucovorin, fluorouracil, irinotecan and oxaliplatin
- FOLFOX: Leucovorin, fluorouracil and oxaliplatin
- FOLFOXIRI: Leucovorin, fluorouracil, oxaliplatin and irinotecan
- Gemcitabine and cisplatin: Gemcitabine and cisplatin
- Gemcitabine and nab-paclitaxel: Gemcitabine and nab-paclitaxel (albumin-bound paclitaxel)
- HiDAC: High dose cytarabine, with or without midostaurin
- Hyper-CVAD: Part A: cyclophosphamide, vincristine, doxorubicin and dexamethasone. Part B: methotrexate and cytarabine
- IBR: Ibrutinib, bendamustine and rituximab
- IRd: Ixazomib, lenalidomide and dexamethasone
- Isa-Pd: Isatuximab, pomalidomide and dexamethasone
- KRd (CRD): Carfilzomib, lenalidomide and dexamethasone
- PBD: Panobinostat, bortezomib and dexamethasone
- POMP: Mercaptopurine, vincristine, methotrexate and prednisone
- R-CHOP: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
- R-DHAP: Rituximab, dexamethasone, cytarabine and cisplatin
- R-GemOx: Rituximab, gemcitabine and oxaliplatin
- RICE: Rituximab, ifosfamide, carboplatin and etoposide
- RVd (VRd): Lenalidomide, bortezomib and dexamethasone
- TC: Docetaxel and cyclophosphamide
- TCHP: Docetaxel, carboplatin, trastuzumab and pertuzumab
- THP: Docetaxel, trastuzumab and pertuzumab
- VAC/IE: Vincristine, doxorubicin and cyclophosphamide, alternating with ifosfamide and etoposide
- Vd: Bortezomib and dexamethasone
- VIP: Etoposide, ifosfamide and cisplatin
- VTd: Bortezomib, thalidomide and dexamethasone
Alkylating agents
- Cyclophosphamide
- Ifosfamide (Ifex)
- Bendamustine (Treanda, Bendeka, Belrapzo)
- Temozolomide (Temodar)
- Melphalan (Alkeran, Evomela, Hepzato)
- Busulfan (Myleran, Busulfex)
- Dacarbazine
- Lurbinectedin (Zepzelca)
- Carmustine (BCNU) (BiCNU, Gliadel)
Platinum chemotherapy
Antimetabolites
- Fluorouracil (5-FU)
- Capecitabine (Xeloda)
- Gemcitabine (Infugem)
- Pemetrexed (Alimta, Pemfexy, Pemrydi RTU)
- Methotrexate (Trexall, Xatmep, Jylamvo)
- Cytarabine
- Azacitidine (Vidaza, Onureg)
- Decitabine (Inqovi)
- Fludarabine
- Hydroxyurea (Hydrea, Droxia, Siklos)
- Trifluridine and tipiracil (Lonsurf)
- Mercaptopurine (6-MP) (Purixan)
- Cladribine
Microtubule medications
- Paclitaxel
- Nab-paclitaxel (paclitaxel protein-bound) (Abraxane)
- Docetaxel (Taxotere)
- Cabazitaxel (Jevtana)
- Vincristine (Vincasar PFS)
- Vinorelbine (Navelbine)
- Eribulin (Halaven)
- Vinblastine
Anthracyclines
- Doxorubicin (Adriamycin)
- Liposomal doxorubicin (Doxil)
- Daunorubicin
- Epirubicin (Ellence)
- Idarubicin (Idamycin PFS)
- Bleomycin
- Mitomycin (Jelmyto, Zusduri)
- Mitoxantrone
Topoisomerase inhibitors
Immunotherapy (checkpoint inhibitors)
- Pembrolizumab (Keytruda, Keytruda Qlex)
- Nivolumab (Opdivo, Opdivo Qvantig)
- Atezolizumab (Tecentriq, Tecentriq Hybreza)
- Durvalumab (Imfinzi)
- Cemiplimab (Libtayo)
- Ipilimumab (Yervoy)
- Tremelimumab (Imjudo)
- Dostarlimab (Jemperli)
- Nivolumab and relatlimab (Opdualag)
- Tislelizumab (Tevimbra)
Antibody drug conjugates
- Trastuzumab deruxtecan (Enhertu)
- Sacituzumab govitecan (Trodelvy)
- Enfortumab vedotin (Padcev)
- Trastuzumab emtansine (Kadcyla)
- Brentuximab vedotin (Adcetris)
- Polatuzumab vedotin (Polivy)
- Datopotamab deruxtecan (Datroway)
- Mirvetuximab soravtansine (Elahere)
- Tisotumab vedotin (Tivdak)
Bispecific antibodies
- Teclistamab (Tecvayli)
- Talquetamab (Talvey)
- Elranatamab (Elrexfio)
- Epcoritamab (Epkinly)
- Glofitamab (Columvi)
- Blinatumomab (Blincyto)
- Tarlatamab (Imdelltra)
- CAR T-cell therapy (Kymriah, Yescarta, Tecartus)
Monoclonal antibodies
- Trastuzumab (Herceptin, Herceptin Hylecta, Ogivri)
- Pertuzumab (Perjeta, Phesgo)
- Bevacizumab (Avastin, Mvasi, Zirabev)
- Ramucirumab (Cyramza)
- Cetuximab (Erbitux)
- Panitumumab (Vectibix)
- Rituximab (Rituxan, Rituxan Hycela, Truxima)
- Obinutuzumab (Gazyva)
- Amivantamab (Rybrevant, Rybrevant Faspro)
Kinase inhibitors
- Osimertinib (Tagrisso)
- Erlotinib (Tarceva)
- Alectinib (Alecensa)
- Lorlatinib (Lorbrena)
- Brigatinib (Alunbrig)
- Crizotinib (Xalkori)
- Capmatinib (Tabrecta)
- Selpercatinib (Retevmo)
- Dabrafenib and trametinib (Tafinlar, Mekinist)
- Encorafenib and binimetinib (Braftovi, Mektovi)
- Sotorasib (Lumakras)
- Adagrasib (Krazati)
- Imatinib (Gleevec, Imkeldi)
- Dasatinib (Sprycel, Phyrago)
- Nilotinib (Tasigna, Danziten)
- Bosutinib (Bosulif)
- Ponatinib (Iclusig)
- Asciminib (Scemblix)
- Lenvatinib (Lenvima)
- Cabozantinib (Cabometyx, Cometriq)
- Sunitinib (Sutent)
- Pazopanib (Votrient)
- Axitinib (Inlyta)
- Regorafenib (Stivarga)
- Sorafenib (Nexavar)
- Tucatinib (Tukysa)
- Lapatinib (Tykerb)
- Neratinib (Nerlynx)
- Entrectinib (Rozlytrek)
- Larotrectinib (Vitrakvi)
- Fruquintinib (Fruzaqla)
Other targeted medications
- Palbociclib (Ibrance)
- Ribociclib (Kisqali, Kisqali Femara Co-Pack)
- Abemaciclib (Verzenio)
- Olaparib (Lynparza)
- Niraparib (Zejula, Akeega)
- Rucaparib (Rubraca)
- Talazoparib (Talzenna)
- Everolimus (Afinitor, Afinitor Disperz)
- Alpelisib (Piqray)
- Capivasertib (Truqap)
- Elacestrant (Orserdu)
Hormone therapy
- Tamoxifen (Soltamox)
- Letrozole (Femara)
- Anastrozole (Arimidex)
- Exemestane (Aromasin)
- Fulvestrant (Faslodex)
- Leuprolide (Lupron Depot, Eligard, Camcevi)
- Degarelix (Firmagon)
- Relugolix (Orgovyx)
- Abiraterone (Zytiga, Yonsa)
- Enzalutamide (Xtandi)
- Apalutamide (Erleada)
- Darolutamide (Nubeqa)
- Goserelin (Zoladex)
Myeloma medications
- Lenalidomide (Revlimid)
- Pomalidomide (Pomalyst)
- Thalidomide (Thalomid)
- Bortezomib (Velcade, Boruzu)
- Carfilzomib (Kyprolis)
- Daratumumab (Darzalex, Darzalex Faspro)
- Isatuximab (Sarclisa, Sarclisa Escena)
- Dexamethasone (Hemady)
- Elotuzumab (Empliciti)
- Ixazomib (Ninlaro)
- Panobinostat (Farydak)
Blood cancer medications
- Ibrutinib (Imbruvica)
- Acalabrutinib (Calquence)
- Zanubrutinib (Brukinsa)
- Pirtobrutinib (Jaypirca)
- Venetoclax (Venclexta)
- Midostaurin (Rydapt)
- Gilteritinib (Xospata)
- Ivosidenib (Tibsovo)
- Ruxolitinib (Jakafi)
- Tretinoin
- Arsenic trioxide (Trisenox)
- Asparaginase (pegaspargase and others) (Oncaspar, Asparlas, Rylaze)
Immune-calming and blood count medications
- Antithymocyte globulin (ATG) (Atgam, Thymoglobulin)
- Cyclosporine (Sandimmune, Neoral, Gengraf)
- Eltrombopag (Promacta, Alvaiz)
Blood thinners
- Apixaban (Eliquis)
- Rivaroxaban (Xarelto)
- Enoxaparin (Lovenox)
- Warfarin (Jantoven)
- Dabigatran (Pradaxa)
- Edoxaban (Savaysa)
- Heparin
Supportive care medications
- Filgrastim (Neupogen, Zarxio, Nivestym)
- Pegfilgrastim (Neulasta, Fulphila, Udenyca)
- Epoetin alfa and darbepoetin alfa (Epogen, Procrit, Retacrit)
- Ondansetron (Zofran)
- Olanzapine (for nausea) (Zyprexa)
- Aprepitant and fosaprepitant (Emend, Cinvanti, Aponvie)
- Prochlorperazine (Compro)
- Denosumab (Xgeva, Prolia)
- Zoledronic acid (Zometa, Reclast)
- Loperamide (Imodium)
- Leucovorin
- Allopurinol (Zyloprim, Aloprim)
- Mesna (Mesnex)
- Prednisone (Rayos)